Sichuan Hebang Biotechnology Corporation Limited (603077.SS)
CNY 1.69
(0.0%)
CNY 1.69
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 4.4 Billion CNY | 112.09% |
| 2022 | 2.07 Billion CNY | 127.59% |
| 2021 | 912.2 Million CNY | 44.05% |
| 2020 | 633.27 Million CNY | -51.94% |
| 2019 | 1.31 Billion CNY | 24.59% |
| 2018 | 1.05 Billion CNY | -0.59% |
| 2017 | 1.06 Billion CNY | 23.09% |
| 2016 | 864.19 Million CNY | 5.32% |
| 2015 | 820.57 Million CNY | -9.02% |
| 2014 | 901.9 Million CNY | 64.44% |
| 2013 | 548.47 Million CNY | 22.17% |
| 2012 | 448.92 Million CNY | 96.25% |
| 2011 | 228.75 Million CNY | 40.12% |
| 2010 | 163.25 Million CNY | 97.92% |
| 2009 | 82.48 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 5.01 Billion CNY | 13.84% |
| 2024 Q2 | 4.66 Billion CNY | -6.86% |
| 2024 Q3 | 4.91 Billion CNY | 5.28% |
| 2023 Q2 | 3.42 Billion CNY | 46.12% |
| 2023 FY | 4.4 Billion CNY | 112.09% |
| 2023 Q4 | 4.4 Billion CNY | 10.19% |
| 2023 Q3 | 3.99 Billion CNY | 16.82% |
| 2023 Q1 | 2.34 Billion CNY | 12.76% |
| 2022 Q3 | 1.29 Billion CNY | 14.0% |
| 2022 Q2 | 1.13 Billion CNY | -11.78% |
| 2022 Q1 | 1.28 Billion CNY | 40.66% |
| 2022 FY | 2.07 Billion CNY | 127.59% |
| 2022 Q4 | 2.07 Billion CNY | 60.89% |
| 2021 FY | 912.2 Million CNY | 44.05% |
| 2021 Q4 | 912.2 Million CNY | 91.93% |
| 2021 Q2 | 623.61 Million CNY | -4.23% |
| 2021 Q3 | 475.29 Million CNY | -23.78% |
| 2021 Q1 | 651.17 Million CNY | 2.83% |
| 2020 Q3 | 624.08 Million CNY | -51.71% |
| 2020 FY | 633.27 Million CNY | -51.94% |
| 2020 Q1 | 1.42 Billion CNY | 8.07% |
| 2020 Q2 | 1.29 Billion CNY | -9.23% |
| 2020 Q4 | 633.27 Million CNY | 1.47% |
| 2019 Q3 | 1.11 Billion CNY | -4.36% |
| 2019 Q2 | 1.16 Billion CNY | 6.01% |
| 2019 Q1 | 1.09 Billion CNY | 3.72% |
| 2019 FY | 1.31 Billion CNY | 24.59% |
| 2019 Q4 | 1.31 Billion CNY | 18.48% |
| 2018 FY | 1.05 Billion CNY | -0.59% |
| 2018 Q4 | 1.05 Billion CNY | 18.51% |
| 2018 Q3 | 892.35 Million CNY | -5.61% |
| 2018 Q2 | 945.4 Million CNY | -18.39% |
| 2018 Q1 | 1.15 Billion CNY | 8.89% |
| 2017 Q4 | 1.06 Billion CNY | 15.71% |
| 2017 FY | 1.06 Billion CNY | 23.09% |
| 2017 Q3 | 919.35 Million CNY | -21.99% |
| 2017 Q2 | 1.17 Billion CNY | 9.12% |
| 2017 Q1 | 1.07 Billion CNY | 24.97% |
| 2016 Q3 | 826.38 Million CNY | 4.14% |
| 2016 Q4 | 864.19 Million CNY | 4.58% |
| 2016 Q1 | 779.95 Million CNY | -4.95% |
| 2016 FY | 864.19 Million CNY | 5.32% |
| 2016 Q2 | 793.56 Million CNY | 1.75% |
| 2015 FY | 820.57 Million CNY | -9.02% |
| 2015 Q1 | 1.02 Billion CNY | 13.49% |
| 2015 Q4 | 820.57 Million CNY | -14.32% |
| 2015 Q3 | 957.71 Million CNY | 2.8% |
| 2015 Q2 | 931.67 Million CNY | -8.98% |
| 2014 FY | 901.9 Million CNY | 64.44% |
| 2014 Q3 | 995.32 Million CNY | 8.05% |
| 2014 Q4 | 901.9 Million CNY | -9.39% |
| 2014 Q2 | 921.21 Million CNY | 52.44% |
| 2014 Q1 | 604.3 Million CNY | 10.18% |
| 2013 Q1 | 552.43 Million CNY | 23.06% |
| 2013 Q2 | 661.36 Million CNY | 19.72% |
| 2013 Q3 | 598.33 Million CNY | -9.53% |
| 2013 Q4 | 548.47 Million CNY | -8.33% |
| 2013 FY | 548.47 Million CNY | 22.17% |
| 2012 FY | 448.92 Million CNY | 96.25% |
| 2012 Q4 | 448.92 Million CNY | 37.48% |
| 2012 Q3 | 326.54 Million CNY | 15.04% |
| 2012 Q2 | 283.84 Million CNY | 0.0% |
| 2011 FY | 228.75 Million CNY | 40.12% |
| 2011 Q4 | 228.75 Million CNY | 0.0% |
| 2010 FY | 163.25 Million CNY | 97.92% |
| 2009 FY | 82.48 Million CNY | 0.0% |